Literature DB >> 17372107

What are the risks of serious infections and malignancies for patients treated with anti-tumor necrosis factor antibodies?

Rosamaria Corona1, Michael Bigby.   

Abstract

Entities:  

Year:  2007        PMID: 17372107     DOI: 10.1001/archderm.143.3.405

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  1 in total

1.  Immunoglobulin subtypes predict therapy response to the biologics in patients with rheumatoid arthritis.

Authors:  Meryem Can; Ahu Najip; Neslihan Yılmaz; Nevsun Inanc; Sule Yavuz
Journal:  Rheumatol Int       Date:  2012-11-21       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.